Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Antibody microarray-based oncoproteomics

In English

Författare

Summary, in English

The driving force behind oncoproteomics is the belief that certain protein signatures or patterns exist that are associated with a particular malignancy. if so, the correlation of clinical parameters with defined protein expression patterns would allow us to predict disease progression and perhaps even postulate improved therapeutic modalities. The technological challenges to achieve these goals are significant, as the human proteome is not defined. No general methodological approach exists today, and human cancer can, furthermore, be divided into several disease subgroups. One potential solution to finding cancer-associated protein signatures is the emerging technology of affinity proteomics. This approach addresses some of the shortcomings of traditional proteomics and combines it with the power of microarrays. The present review focuses on the role of antibody microarrays in oncoproteomics and its potential to provide a truly proteome-wide analytical approach.

Publiceringsår

2006

Språk

Engelska

Sidor

833-838

Publikation/Tidskrift/Serie

Expert Opinion on Biological Therapy

Volym

6

Issue

8

Dokumenttyp

Artikel i tidskrift

Förlag

Ashley Publications

Ämne

  • Immunology in the medical area

Nyckelord

  • recombinant
  • antibody
  • proteome analysis
  • microarray
  • affinity proteomics
  • cancer

Status

Published

ISBN/ISSN/Övrigt

  • ISSN: 1471-2598